Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CERITINIB vs CETRORELIX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CERITINIB vs CETRORELIX: Safety Overview

Metric CERITINIB CETRORELIX
Total FAERS Reports 2,796 441
Deaths Reported 786 4
Death Rate 28.1% 0.9%
Hospitalizations 804 160
Average Patient Age 55.6 yrs 34.3 yrs
% Female Patients 55.1% 99.3%
FDA Approval Date Apr 29, 2014 Apr 16, 2024
Manufacturer Novartis Pharmaceuticals Corporation Gland Pharma Limited
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued Prescription